Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
Roxanne A W PloumenEva L ClaassensLoes F S KooremanKristien B M I KeymeulenMaartje A C E van KatsSander M J van KuijkSabine SieslingThiemo J A van NijnattenMarjolein L SmidtPublished in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (2024)
The presence of DCIS is associated with higher rates of positive surgical margins, but not with LRR and lower OS when adjusted for confounders. Further research is necessary to adequately select IBC+DCIS patients for BCS after NST.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- rectal cancer
- stem cells
- squamous cell carcinoma
- patient reported outcomes
- locally advanced
- coronary artery disease
- cell therapy
- percutaneous coronary intervention
- drug induced
- early breast cancer